As of December 31, 2024, the Company had cash and cash equivalents in the amount of $15.6 million, compared to $5.3 million ...

Bleakley Financial Group LLC cut its stake in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 9.4% in the ...

ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical ...

While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...

Norwegian land-based salmon producer Salmon Evolution recently posted its best fourth-quarter results to date.

Sage Therapeutics, Inc. SAGE reported a loss of $1.56 per share for the fourth quarter of 2024, wider than the Zacks ...

The average pay raise is expected to be between 5% and 8%, effective from April. The move comes as IT companies are seeing a surge in demand and predicting an increase in budgets for the next fiscal ...

Q4 2024 Earnings Call Transcript February 11, 2025 Carrier Global Corporation beats earnings expectations. Reported EPS is $0.54, expectations were $0.5. Operator: Good morning, and welcome to Carrier ...

StockNews.com lowered shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a hold rating to a sell rating in a ...

The positive trial results have not only demonstrated rosnilimab's potential in treating RA but have also validated AnaptysBio's scientific approach in targeting PD-1 co-inhibitory receptors on ...

Considering the nascent bull market phase oil prices are in right now, the short-term outlook for producers looks promising.

Industry Leaders Converge at the 4th Edition Manufacturing 5.0 Event to Shape the Future of Global Manufacturing Harman (a ...